DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer

DEK is a transcription factor involved in stabilization of heterochromatin and cruciform structures. It plays an important role in development and progression of different types of cancer. This study aims to analyze the role of DEK in metastatic colorectal cancer.